Global Anthrax Vaccines Market Insights, Forecast to 2025

SKU ID :QYR-13730288 | Published Date: 05-Mar-2019 | No. of pages: 127
Table of Contents 1 Study Coverage 1.1 Anthrax Vaccines Product 1.2 Market Segments 1.3 Key Manufacturers Covered 1.4 Market by Type 1.4.1 Global Anthrax Vaccines Market Size Growth Rate by Product 1.4.2 Live Vaccines 1.4.3 Cell free PA Vaccines 1.5 Market by End User 1.5.1 Global Anthrax Vaccines Market Size Growth Rate by End User 1.5.2 Human Use 1.5.3 Animal Use 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global Anthrax Vaccines Market Size 2.1.1 Global Anthrax Vaccines Revenue 2014-2025 2.1.2 Global Anthrax Vaccines Sales 2014-2025 2.2 Anthrax Vaccines Growth Rate by Regions 2.2.1 Global Anthrax Vaccines Sales by Regions 2.2.2 Global Anthrax Vaccines Revenue by Regions 3 Breakdown Data by Manufacturers 3.1 Anthrax Vaccines Sales by Manufacturers 3.1.1 Anthrax Vaccines Sales by Manufacturers 3.1.2 Anthrax Vaccines Sales Market Share by Manufacturers 3.1.3 Global Anthrax Vaccines Market Concentration Ratio (CR5 and HHI) 3.2 Anthrax Vaccines Revenue by Manufacturers 3.2.1 Anthrax Vaccines Revenue by Manufacturers (2014-2019) 3.2.2 Anthrax Vaccines Revenue Share by Manufacturers (2014-2019) 3.3 Anthrax Vaccines Price by Manufacturers 3.4 Anthrax Vaccines Manufacturing Base Distribution, Product Types 3.4.1 Anthrax Vaccines Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Anthrax Vaccines Product Type 3.4.3 Date of International Manufacturers Enter into Anthrax Vaccines Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Product 4.1 Global Anthrax Vaccines Sales by Product 4.2 Global Anthrax Vaccines Revenue by Product 4.3 Anthrax Vaccines Price by Product 5 Breakdown Data by End User 5.1 Overview 5.2 Global Anthrax Vaccines Breakdown Data by End User 6 North America 6.1 North America Anthrax Vaccines by Countries 6.1.1 North America Anthrax Vaccines Sales by Countries 6.1.2 North America Anthrax Vaccines Revenue by Countries 6.1.3 United States 6.1.4 Canada 6.1.5 Mexico 6.2 North America Anthrax Vaccines by Product 6.3 North America Anthrax Vaccines by End User 7 Europe 7.1 Europe Anthrax Vaccines by Countries 7.1.1 Europe Anthrax Vaccines Sales by Countries 7.1.2 Europe Anthrax Vaccines Revenue by Countries 7.1.3 Germany 7.1.4 France 7.1.5 UK 7.1.6 Italy 7.1.7 Russia 7.2 Europe Anthrax Vaccines by Product 7.3 Europe Anthrax Vaccines by End User 8 Asia Pacific 8.1 Asia Pacific Anthrax Vaccines by Countries 8.1.1 Asia Pacific Anthrax Vaccines Sales by Countries 8.1.2 Asia Pacific Anthrax Vaccines Revenue by Countries 8.1.3 China 8.1.4 Japan 8.1.5 Korea 8.1.6 India 8.1.7 Australia 8.1.8 Indonesia 8.1.9 Malaysia 8.1.10 Philippines 8.1.11 Thailand 8.1.12 Vietnam 8.1.13 Singapore 8.2 Asia Pacific Anthrax Vaccines by Product 8.3 Asia Pacific Anthrax Vaccines by End User 9 Central & South America 9.1 Central & South America Anthrax Vaccines by Countries 9.1.1 Central & South America Anthrax Vaccines Sales by Countries 9.1.2 Central & South America Anthrax Vaccines Revenue by Countries 9.1.3 Brazil 9.2 Central & South America Anthrax Vaccines by Product 9.3 Central & South America Anthrax Vaccines by End User 10 Middle East and Africa 10.1 Middle East and Africa Anthrax Vaccines by Countries 10.1.1 Middle East and Africa Anthrax Vaccines Sales by Countries 10.1.2 Middle East and Africa Anthrax Vaccines Revenue by Countries 10.1.3 GCC Countries 10.1.4 Turkey 10.1.5 Egypt 10.1.6 South Africa 10.2 Middle East and Africa Anthrax Vaccines by Product 10.3 Middle East and Africa Anthrax Vaccines by End User 11 Company Profiles 11.1 Emergent BioSolutions 11.1.1 Emergent BioSolutions Company Details 11.1.2 Company Business Overview 11.1.3 Emergent BioSolutions Anthrax Vaccines Sales, Revenue and Gross Margin (2014-2019) 11.1.4 Emergent BioSolutions Anthrax Vaccines Products Offered 11.1.5 Emergent BioSolutions Recent Development 11.2 Merial 11.2.1 Merial Company Details 11.2.2 Company Business Overview 11.2.3 Merial Anthrax Vaccines Sales, Revenue and Gross Margin (2014-2019) 11.2.4 Merial Anthrax Vaccines Products Offered 11.2.5 Merial Recent Development 11.3 Merck 11.3.1 Merck Company Details 11.3.2 Company Business Overview 11.3.3 Merck Anthrax Vaccines Sales, Revenue and Gross Margin (2014-2019) 11.3.4 Merck Anthrax Vaccines Products Offered 11.3.5 Merck Recent Development 11.4 Zoetis  11.4.1 Zoetis  Company Details 11.4.2 Company Business Overview 11.4.3 Zoetis  Anthrax Vaccines Sales, Revenue and Gross Margin (2014-2019) 11.4.4 Zoetis  Anthrax Vaccines Products Offered 11.4.5 Zoetis  Recent Development 11.5 Bayer Sanidad Animal 11.5.1 Bayer Sanidad Animal Company Details 11.5.2 Company Business Overview 11.5.3 Bayer Sanidad Animal Anthrax Vaccines Sales, Revenue and Gross Margin (2014-2019) 11.5.4 Bayer Sanidad Animal Anthrax Vaccines Products Offered 11.5.5 Bayer Sanidad Animal Recent Development 11.6 Colorado Serum 11.6.1 Colorado Serum Company Details 11.6.2 Company Business Overview 11.6.3 Colorado Serum Anthrax Vaccines Sales, Revenue and Gross Margin (2014-2019) 11.6.4 Colorado Serum Anthrax Vaccines Products Offered 11.6.5 Colorado Serum Recent Development 11.7 PharmAthene 11.7.1 PharmAthene Company Details 11.7.2 Company Business Overview 11.7.3 PharmAthene Anthrax Vaccines Sales, Revenue and Gross Margin (2014-2019) 11.7.4 PharmAthene Anthrax Vaccines Products Offered 11.7.5 PharmAthene Recent Development 11.8 Tiankang 11.8.1 Tiankang Company Details 11.8.2 Company Business Overview 11.8.3 Tiankang Anthrax Vaccines Sales, Revenue and Gross Margin (2014-2019) 11.8.4 Tiankang Anthrax Vaccines Products Offered 11.8.5 Tiankang Recent Development 11.9 Biogénesis-Bago 11.9.1 Biogénesis-Bago Company Details 11.9.2 Company Business Overview 11.9.3 Biogénesis-Bago Anthrax Vaccines Sales, Revenue and Gross Margin (2014-2019) 11.9.4 Biogénesis-Bago Anthrax Vaccines Products Offered 11.9.5 Biogénesis-Bago Recent Development 11.10 CAVAC 11.10.1 CAVAC Company Details 11.10.2 Company Business Overview 11.10.3 CAVAC Anthrax Vaccines Sales, Revenue and Gross Margin (2014-2019) 11.10.4 CAVAC Anthrax Vaccines Products Offered 11.10.5 CAVAC Recent Development 11.11 Rosenbusch 11.12 Agrovet 11.13 Vecol 11.14 CVCRI 11.15 IVPM 11.16 Prondil 11.17 CDV 11.18 Indian Immunologicals 11.19 Botswana Vaccine Institute 11.20 Ceva Santé Animale 11.21 Intervac 11.22 JOVAC 12 Future Forecast 12.1 Anthrax Vaccines Market Forecast by Regions 12.1.1 Global Anthrax Vaccines Sales Forecast by Regions 2019-2025 12.1.2 Global Anthrax Vaccines Revenue Forecast by Regions 2019-2025 12.2 Anthrax Vaccines Market Forecast by Product 12.2.1 Global Anthrax Vaccines Sales Forecast by Product 2019-2025 12.2.2 Global Anthrax Vaccines Revenue Forecast by Product 2019-2025 12.3 Anthrax Vaccines Market Forecast by End User 12.4 North America Anthrax Vaccines Forecast 12.5 Europe Anthrax Vaccines Forecast 12.6 Asia Pacific Anthrax Vaccines Forecast 12.7 Central & South America Anthrax Vaccines Forecast 12.8 Middle East and Africa Anthrax Vaccines Forecast 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Macroscopic Indicators 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Anthrax Vaccines Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer
List of Tables and Figures Figure Anthrax Vaccines Product Picture Table Anthrax Vaccines Market Segments Table Key Manufacturers Anthrax Vaccines Covered Table Global Anthrax Vaccines Market Size Growth Rate by Product 2019-2025 (M Doses) & (Million US$) Figure Global Anthrax Vaccines Sales Market Share by Product 2014-2025 Figure Live Vaccines Product Picture Table Major Manufacturers of Live Vaccines Figure Cell free PA Vaccines Product Picture Table Major Manufacturers of Cell free PA Vaccines Table Global Anthrax Vaccines Market Size Growth Rate by End User 2019-2025 (M Doses) Figure Human Use Figure Animal Use Figure Anthrax Vaccines Report Years Considered Figure Global Anthrax Vaccines Market Size 2014-2025 (Million US$) Figure Global Anthrax Vaccines Sales 2014-2025 (M Doses) Table Global Anthrax Vaccines Market Size by Regions 2014-2019 (M Doses) & (Million US$) Table Global Anthrax Vaccines Sales by Regions 2014-2019 (M Doses) Table Global Anthrax Vaccines Sales Market Share by Regions 2014-2019 Figure Global Anthrax Vaccines Sales Market Share by Regions 2014-2019 Figure 2018 Global Anthrax Vaccines Sales Market Share by Regions Table Global Anthrax Vaccines Revenue by Regions 2014-2019 (Million US$) Table Global Anthrax Vaccines Revenue Market Share by Regions 2014-2019 Figure Global Anthrax Vaccines Revenue Market Share by Regions 2014-2019 Figure 2018 Global Anthrax Vaccines Revenue Market Share by Regions Table Global Anthrax Vaccines Sales by Manufacturers (2014-2019) (M Doses) Table Global Anthrax Vaccines Sales Share by Manufacturers (2014-2019) Figure Global Anthrax Vaccines Sales Share by Manufacturers in 2018 Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Anthrax Vaccines Revenue by Manufacturers (2014-2019) (Million USD) Table Anthrax Vaccines Revenue Share by Manufacturers (2014-2019) Figure Anthrax Vaccines Value Share by Manufacturers in 2018 Table Key Manufacturers Anthrax Vaccines Price (2014-2019) (USD/Doses) Table Anthrax Vaccines Manufacturers Manufacturing Base Distribution and Headquarters Table Manufacturers Anthrax Vaccines Product Type Table Date of International Manufacturers Enter into Anthrax Vaccines Market Table Manufacturers Mergers & Acquisitions, Expansion Plans Table Global Anthrax Vaccines Sales by Product (2014-2019) (M Doses) Table Global Anthrax Vaccines Sales Share by Product (2014-2019) Figure Global Anthrax Vaccines Sales Market Share by Product (2014-2019) Figure Global Anthrax Vaccines Sales Market Share by Product in 2018 Table Global Anthrax Vaccines Revenue by Product (2014-2019) (Million US$) Table Global Anthrax Vaccines Revenue Share by Product (2014-2019) Figure Global Anthrax Vaccines Revenue Market Share by Product (2014-2019) Figure Global Anthrax Vaccines Revenue Market Share by Product in 2018 Table Anthrax Vaccines Price by Product 2014-2019 (USD/Doses) Table Global Anthrax Vaccines Sales by End User (2014-2019) (M Doses) Table Global Anthrax Vaccines Sales Share by End User (2014-2019) Figure Global Sales Anthrax Vaccines Market Share by End User (2014-2019) Figure Global Sales Anthrax Vaccines Market Share by End User in 2018 Figure North America Anthrax Vaccines Sales Growth Rate 2014-2019 (M Doses) Figure North America Anthrax Vaccines Revenue Growth Rate 2014-2019 (Million US$) Table North America Anthrax Vaccines Sales by Countries (2014-2019) (M Doses) Table North America Anthrax Vaccines Sales Market Share by Countries (2014-2019) Figure 2018 North America Anthrax Vaccines Sales Market Share by Countries Table North America Anthrax Vaccines Revenue by Countries (2014-2019) (Million US$) Table North America Anthrax Vaccines Revenue Market Share by Countries (2014-2019) Figure 2018 North America Anthrax Vaccines Revenue Market Share by Countries Figure United States Anthrax Vaccines Sales Growth Rate (2014-2019) (M Doses) Figure United States Anthrax Vaccines Revenue Growth Rate (2014-2019) (M Doses) Figure Canada Anthrax Vaccines Sales Growth Rate (2014-2019) (M Doses) Figure Canada Anthrax Vaccines Revenue Growth Rate (2014-2019) (Million US$) Figure Mexico Anthrax Vaccines Sales Growth Rate (2014-2019) (M Doses) Figure Mexico Anthrax Vaccines Revenue Growth Rate (2014-2019) (Million US$) Table North America Anthrax Vaccines Sales by Product (2014-2019) (M Doses) Table North America Anthrax Vaccines Sales Market Share by Product (2014-2019) Figure 2018 North America Anthrax Vaccines Market Share by Product Table North America Anthrax Vaccines Sales by End User (2014-2019) (M Doses) Table North America Anthrax Vaccines Sales Market Share by End User (2014-2019) Figure 2018 North America Anthrax Vaccines Market Share by End User Figure Europe Anthrax Vaccines Sales Growth Rate 2014-2019 (M Doses) Figure Europe Anthrax Vaccines Revenue Growth Rate 2014-2019 (Million US$) Table Europe Anthrax Vaccines Sales by Countries (2014-2019) (M Doses) Table Europe Anthrax Vaccines Sales Market Share by Countries (2014-2019) Figure 2018 Europe Anthrax Vaccines Sales Market Share by Countries Table Europe Anthrax Vaccines Revenue by Countries (2014-2019) (Million US$) Table Europe Anthrax Vaccines Revenue Market Share by Countries (2014-2019) Figure 2018 Europe Anthrax Vaccines Revenue Market Share by Countries Figure Germany Anthrax Vaccines Sales Growth Rate (2014-2019) (M Doses) Figure Germany Anthrax Vaccines Revenue Growth Rate (2014-2019) (Million US$) Figure France Anthrax Vaccines Sales Growth Rate (2014-2019) (M Doses) Figure France Anthrax Vaccines Revenue Growth Rate (2014-2019) (Million US$) Figure UK Anthrax Vaccines Sales Growth Rate (2014-2019) (M Doses) Figure UK Anthrax Vaccines Revenue Growth Rate (2014-2019) (Million US$) Figure Italy Anthrax Vaccines Sales Growth Rate (2014-2019) (M Doses) Figure Italy Anthrax Vaccines Revenue Growth Rate (2014-2019) (Million US$) Figure Russia Anthrax Vaccines Sales Growth Rate (2014-2019) (M Doses) Figure Russia Anthrax Vaccines Revenue Growth Rate (2014-2019) (Million US$) Table Europe Anthrax Vaccines Sales by Product (2014-2019) (M Doses) Table Europe Anthrax Vaccines Sales Market Share by Product (2014-2019) Figure 2018 Europe Anthrax Vaccines Market Share by Product Table Europe Anthrax Vaccines Sales by End User (2014-2019) (M Doses) Table Europe Anthrax Vaccines Sales Market Share by End User (2014-2019) Figure 2018 Europe Anthrax Vaccines Market Share by End User Figure Asia Pacific Anthrax Vaccines Sales Growth Rate 2014-2019 (M Doses) Figure Asia Pacific Anthrax Vaccines Revenue Growth Rate 2014-2019 (Million US$) Table Asia Pacific Anthrax Vaccines Sales by Countries (2014-2019) (M Doses) Table Asia Pacific Anthrax Vaccines Sales Market Share by Countries (2014-2019) Figure 2018 Asia Pacific Anthrax Vaccines Sales Market Share by Countries Table Asia Pacific Anthrax Vaccines Revenue by Countries (2014-2019) (Million US$) Table Asia Pacific Anthrax Vaccines Revenue Market Share by Countries (2014-2019) Figure 2018 Asia Pacific Anthrax Vaccines Revenue Market Share by Countries Figure China Anthrax Vaccines Sales Growth Rate (2014-2019) (M Doses) Figure China Anthrax Vaccines Revenue Growth Rate (2014-2019) (Million US$) Figure Japan Anthrax Vaccines Sales Growth Rate (2014-2019) (M Doses) Figure Japan Anthrax Vaccines Revenue Growth Rate (2014-2019) (Million US$) Figure Korea Anthrax Vaccines Sales Growth Rate (2014-2019) (M Doses) Figure Korea Anthrax Vaccines Revenue Growth Rate (2014-2019) (Million US$) Figure India Anthrax Vaccines Sales Growth Rate (2014-2019) (M Doses) Figure India Anthrax Vaccines Revenue Growth Rate (2014-2019) (Million US$) Figure Australia Anthrax Vaccines Sales Growth Rate (2014-2019) (M Doses) Figure Australia Anthrax Vaccines Revenue Growth Rate (2014-2019) (Million US$) Figure Indonesia Anthrax Vaccines Sales Growth Rate (2014-2019) (M Doses) Figure Indonesia Anthrax Vaccines Revenue Growth Rate (2014-2019) (Million US$) Figure Malaysia Anthrax Vaccines Sales Growth Rate (2014-2019) (M Doses) Figure Malaysia Anthrax Vaccines Revenue Growth Rate (2014-2019) (Million US$) Figure Philippines Anthrax Vaccines Sales Growth Rate (2014-2019) (M Doses) Figure Philippines Anthrax Vaccines Revenue Growth Rate (2014-2019) (Million US$) Figure Thailand Anthrax Vaccines Sales Growth Rate (2014-2019) (M Doses) Figure Thailand Anthrax Vaccines Revenue Growth Rate (2014-2019) (Million US$) Figure Vietnam Anthrax Vaccines Sales Growth Rate (2014-2019) (M Doses) Figure Vietnam Anthrax Vaccines Revenue Growth Rate (2014-2019) (Million US$) Figure Singapore Anthrax Vaccines Sales Growth Rate (2014-2019) (M Doses) Figure Singapore Anthrax Vaccines Revenue Growth Rate (2014-2019) (Million US$) Table Asia Pacific Anthrax Vaccines Sales by Product (2014-2019) (M Doses) Table Asia Pacific Anthrax Vaccines Sales Market Share by Product (2014-2019) Figure 2018 Asia Pacific Anthrax Vaccines Market Share by Product Table Asia Pacific Anthrax Vaccines Sales by End User (2014-2019) (M Doses) Table Asia Pacific Anthrax Vaccines Sales Market Share by End User (2014-2019) Figure 2018 Asia Pacific Anthrax Vaccines Market Share by End User Figure Central & South America Anthrax Vaccines Sales Growth Rate 2014-2019 (M Doses) Figure Central & South America Anthrax Vaccines Revenue Growth Rate 2014-2019 (Million US$) Table Central & South America Anthrax Vaccines Sales by Countries (2014-2019) (M Doses) Table Central & South America Anthrax Vaccines Sales Market Share by Countries (2014-2019) Figure 2018 Central & South America Anthrax Vaccines Sales Market Share by Countries Table Central & South America Anthrax Vaccines Revenue by Countries (2014-2019) (Million US$) Table Central & South America Anthrax Vaccines Revenue Market Share by Countries (2014-2019) Figure 2018 Central & South America Anthrax Vaccines Revenue Market Share by Countries Figure Brazil Anthrax Vaccines Sales Growth Rate (2014-2019) (M Doses) Figure Brazil Anthrax Vaccines Revenue Growth Rate (2014-2019) (Million US$) Figure Argentina Anthrax Vaccines Sales Growth Rate (2014-2019) (M Doses) Figure Argentina Anthrax Vaccines Revenue Growth Rate (2014-2019) (Million US$) Table Central & South America Anthrax Vaccines Sales by Product (2014-2019) (M Doses) Table Central & South America Anthrax Vaccines Sales Market Share by Product (2014-2019) Figure 2018 Central & South America Anthrax Vaccines Market Share by Product Table Central & South America Anthrax Vaccines Sales by End User (2014-2019) (M Doses) Table Central & South America Anthrax Vaccines Sales Market Share by End User (2014-2019) Figure 2018 Central & South America Anthrax Vaccines Market Share by End User Figure Middle East and Africa Anthrax Vaccines Sales Growth Rate 2014-2019 (M Doses) Figure Middle East and Africa Anthrax Vaccines Revenue Growth Rate 2014-2019 (Million US$) Table Middle East and Africa Anthrax Vaccines Sales by Countries (2014-2019) (M Doses) Table Middle East and Africa Anthrax Vaccines Sales Market Share by Countries (2014-2019) Figure 2018 Middle East and Africa Anthrax Vaccines Sales Market Share by Countries Table Middle East and Africa Anthrax Vaccines Revenue by Countries (2014-2019) (Million US$) Table Middle East and Africa Anthrax Vaccines Revenue Market Share by Countries (2014-2019) Figure 2018 Middle East and Africa Anthrax Vaccines Revenue Market Share by Countries Figure GCC Countries Anthrax Vaccines Sales Growth Rate (2014-2019) (M Doses) Figure GCC Countries Anthrax Vaccines Revenue Growth Rate (2014-2019) (Million US$) Figure Turkey Anthrax Vaccines Sales Growth Rate (2014-2019) (M Doses) Figure Turkey Anthrax Vaccines Revenue Growth Rate (2014-2019) (Million US$) Figure Egypt Anthrax Vaccines Sales Growth Rate (2014-2019) (M Doses) Figure Egypt Anthrax Vaccines Revenue Growth Rate (2014-2019) (Million US$) Figure South Africa Anthrax Vaccines Sales Growth Rate (2014-2019) (M Doses) Figure South Africa Anthrax Vaccines Revenue Growth Rate (2014-2019) (Million US$) Table Middle East and Africa Anthrax Vaccines Sales by Product (2014-2019) (M Doses) Table Middle East and Africa Anthrax Vaccines Sales Market Share by Product (2014-2019) Figure 2018 Middle East and Africa Anthrax Vaccines Market Share by Product Table Middle East and Africa Anthrax Vaccines Sales by End User (2014-2019) (M Doses) Table Middle East and Africa Anthrax Vaccines Sales Market Share by End User (2014-2019) Figure 2018 Middle East and Africa Anthrax Vaccines Market Share by End User Table Emergent BioSolutions Company Details Table Emergent BioSolutions Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2014-2019) Table Emergent BioSolutions Recent Development Table Merial Company Details Table Merial Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2014-2019) Table Merial Recent Development Table Merck Company Details Table Merck Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2014-2019) Table Merck Recent Development Table Zoetis  Company Details Table Zoetis  Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2014-2019) Table Zoetis  Recent Development Table Bayer Sanidad Animal Company Details Table Bayer Sanidad Animal Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2014-2019) Table Bayer Sanidad Animal Recent Development Table Colorado Serum Company Details Table Colorado Serum Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2014-2019) Table Colorado Serum Recent Development Table PharmAthene Company Details Table PharmAthene Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2014-2019) Table PharmAthene Recent Development Table Tiankang Company Details Table Tiankang Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2014-2019) Table Tiankang Recent Development Table Biogénesis-Bago Company Details Table Biogénesis-Bago Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2014-2019) Table Biogénesis-Bago Recent Development Table CAVAC Company Details Table CAVAC Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2014-2019) Table CAVAC Recent Development Table Rosenbusch Company Details Table Agrovet Company Details Table Vecol Company Details Table CVCRI Company Details Table IVPM Company Details Table Prondil Company Details Table CDV Company Details Table Indian Immunologicals Company Details Table Botswana Vaccine Institute Company Details Table Ceva Santé Animale Company Details Table Intervac Company Details Table JOVAC Company Details Table Global Anthrax Vaccines Sales Forecast by Regions 2019-2025 (M Doses) Table Global Anthrax Vaccines Sales Market Share Forecast by Regions 2019-2025 Table Global Anthrax Vaccines Revenue Forecast by Regions 2019-2025 (Million US$) Table Global Anthrax Vaccines Revenue Market Share Forecast by Regions 2019-2025 Table Global Anthrax Vaccines Sales Forecast by Product 2019-2025 (M Doses) Table Global Anthrax Vaccines Sales Market Share Forecast by Product 2019-2025 Table Global Anthrax Vaccines Revenue Forecast by Product 2019-2025 (Million US$) Table Global Anthrax Vaccines Revenue Market Share Forecast by Product 2019-2025 Table Global Anthrax Vaccines Sales Forecast by End User 2019-2025 (M Doses) Table Global Anthrax Vaccines Sales Market Share Forecast by End User 2019-2025 Figure North America Anthrax Vaccines Sales Growth Rate Forecast (2019-2025) (M Doses) Figure North America Anthrax Vaccines Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Europe Anthrax Vaccines Sales Growth Rate Forecast (2019-2025) (M Doses) Figure Europe Anthrax Vaccines Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Asia Pacific Anthrax Vaccines Sales Growth Rate Forecast (2019-2025) (M Doses) Figure Asia Pacific Anthrax Vaccines Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Central & South America Anthrax Vaccines Sales Growth Rate Forecast (2019-2025) (M Doses) Figure Central & South America Anthrax Vaccines Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Middle East and Africa Anthrax Vaccines Sales Growth Rate Forecast (2019-2025) (M Doses) Figure Middle East and Africa Anthrax Vaccines Revenue Growth Rate Forecast (2019-2025) (Million US$) Table Anthrax Vaccines Value Chain Table Anthrax Vaccines Customers List Table Anthrax Vaccines Distributors List Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources
Emergent BioSolutions Merial Merck Zoetis  Bayer Sanidad Animal Colorado Serum PharmAthene Tiankang Biogénesis-Bago CAVAC Rosenbusch Agrovet Vecol CVCRI IVPM Prondil CDV Indian Immunologicals Botswana Vaccine Institute Ceva Santé Animale Intervac JOVAC
  • PRICE
  • $3900
    $7800

Our Clients